Spectrum Pharmaceuticals is a biotech company focused on the acquisition, development and commercialization of drug products, with a primary focus in oncology and hematology. The company markets three oncology drugs: FUSILEV®, for Injection in the U.S.; FOLOTYN®, also marketed in the U.S.; and ZEVALIN® Injection for intravenous use, for which the company has worldwide marketing rights. For more information visit the company’s Web site at: www.sppirx.com.

Aegis Capital Corp. is a full service retail and institutional broker-dealer located in New York City. Aegis Capital’s management is committed to providing the highest level of service to its clients. The firm realizes this goal by running an independent, conflict-free platform that is focused on enhancing the goals of clients by bringing unencumbered advice, which enables them to freely create a plan centered on each client. For more information on Aegis Capital, visit www.aegiscapcorp.com.

Let us hear your thoughts below: